Rock Springs Capital Management LP Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$3.2T
Holdings
130
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (130 positions)
| Stock | Value |
|---|---|
UNHUNITEDHEALTH GROUP INC | $173.7M |
NBIXNEUROCRINE BIOSCIENCES INC | $137.4M |
WCGEURWELLCARE HEALTH PLANS INC | $105.8M |
AMRNAMARIN CORP PLC | $99.7M |
ISRGINTUITIVE SURGICAL INC | $90.2M |
JNJJOHNSON & JOHNSON | $81.3M |
HCAHCA HEALTHCARE INC | $69.1M |
HUMHUMANA INC | $67.8M |
EHCENCOMPASS HEALTH CORP | $56.5M |
BSXBOSTON SCIENTIFIC CORP | $54.3M |
PCRXPACIRA BIOSCIENCES | $52.1M |
—EPIZYME INC | $50.4M |
TFXTELEFLEX INC | $48.9M |
PODDINSULET CORP | $44.6M |
SRPTSAREPTA THERAPEUTICS INC | $44.6M |
VRTXVERTEX PHARMACEUTICALS INC | $44.4M |
BAXBAXTER INTL INC | $43.9M |
EWEDWARDS LIFESCIENCES CORP | $42.8M |
IRTCIRHYTHM TECHNOLOGIES INC | $42.5M |
ALNYALNYLAM PHARMACEUTICALS INC | $41.9M |
PENPENUMBRA INC | $39.8M |
ARGXARGENX SE | $39.7M |
EXASEXACT SCIENCES CORP | $38.8M |
MRTXEURMIRATI THERAPEUTICS INC | $38.7M |
ARDXARDELYX INC | $36.4M |
GLPGGALAPAGOS NV | $36.2M |
ONCBEIGENE LTD | $35.6M |
—RA PHARMACEUTICALS INC | $35.2M |
CHRSCOHERUS BIOSCIENCES INC | $35.1M |
APREAPREA THERAPEUTICS INC | $33.2M |
NVROEURNEVRO CORP | $32.8M |
COLLCOLLEGIUM PHARMACEUTICAL INC | $32.4M |
ACHCACADIA HEALTHCARE COMPANY IN | $32.4M |
IDXXIDEXX LABS INC | $31.4M |
AFWALIGN TECHNOLOGY INC | $30.9M |
ASMBASSEMBLY BIOSCIENCES INC | $30.7M |
AGIOAGIOS PHARMACEUTICALS INC | $30.6M |
2L9BLUEPRINT MEDICINES CORP | $30.6M |
MIRMMIRUM PHARMACEUTICALS INC | $30.5M |
AXNX*AXONICS MODULATION TECH INC | $30.5M |
AMGNAMGEN INC | $30.4M |
RAREULTRAGENYX PHARMACEUTICAL IN | $29.9M |
ASNDASCENDIS PHARMA A S | $29.7M |
QUREUNIQURE NV | $28.7M |
ACADACADIA PHARMACEUTICALS INC | $28.7M |
BMRNBIOMARIN PHARMACEUTICAL INC | $28.5M |
SGENEURSEATTLE GENETICS INC | $27.7M |
TMOTHERMO FISHER SCIENTIFIC INC | $26.3M |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $26.3M |
—MEDICINES CO | $26.1M |
ZLABZAI LAB LTD | $26.0M |
—AUDENTES THERAPEUTICS INC | $24.5M |
WSTWEST PHARMACEUTICAL SVSC INC | $22.9M |
MDGLMADRIGAL PHARMACEUTICALS INC | $22.8M |
ALLKGUSDALLAKOS INC | $22.4M |
—ACHILLION PHARMACEUTICALS IN | $22.2M |
INCYINCYTE CORP | $21.8M |
—PORTOLA PHARMACEUTICALS INC | $21.5M |
—IMMUNOMEDICS INC | $21.2M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $21.1M |
FRPTFRESHPET INC | $21.0M |
—RADIUS HEALTH INC | $20.2M |
—INTERSECT ENT INC | $19.9M |
NVTA1EURINVITAE CORP | $19.4M |
IM8NINSMED INC | $19.1M |
—FORTY SEVEN INC | $17.7M |
TBPHTHERAVANCE BIOPHARMA INC | $17.0M |
ADPTADAPTIVE BIOTECHNOLOGIES COR | $16.3M |
CICIGNA CORP NEW | $15.3M |
HQYHEALTHEQUITY INC | $15.2M |
OSWONESPAWORLD HOLDINGS LIMITED | $15.2M |
PHRPHREESIA INC | $15.1M |
GHGUARDANT HEALTH INC | $14.8M |
NVCRNOVOCURE LTD | $14.5M |
CNCCENTENE CORP DEL | $14.4M |
—ODONATE THERAPEUTICS INC | $14.0M |
KRTXKARUNA THERAPEUTICS INC | $13.6M |
FGENEURFIBROGEN INC | $13.1M |
—ZOGENIX INC | $13.0M |
RIGLUSDRIGEL PHARMACEUTICALS INC | $11.8M |
—MYOKARDIA INC | $11.7M |
—CONSTELLATION PHARMCETICLS I | $11.0M |
—BIOHAVEN PHARMACTL HLDG CO L | $10.9M |
ARVNARVINAS INC | $10.3M |
—DERMIRA INC | $9.9M |
AM6AMICUS THERAPEUTICS INC | $9.7M |
BMYBRISTOL MYERS SQUIBB CO | $9.6M |
DVAXDYNAVAX TECHNOLOGIES CORP | $9.0M |
FIXXEURHOMOLOGY MEDICINES INC | $8.8M |
—MEDICINES CO | $8.7M |
—RETROPHIN INC | $8.2M |
RYTMRHYTHM PHARMACEUTICALS INC | $7.9M |
—MOMENTA PHARMACEUTICALS INC | $7.9M |
—MYOVANT SCIENCES LTD | $7.8M |
—TRANSLATE BIO INC | $7.7M |
—MERSANA THERAPEUTICS INC | $7.1M |
—PHASEBIO PHARMACEUTICALS INC | $6.9M |
ICPTUSDINTERCEPT PHARMACEUTICALS IN | $6.7M |
GRTXGALERA THERAPEUTICS INC | $6.6M |
CGENCOMPUGEN LTD | $6.6M |
Page 1 of 2Next